A Compensating Skin Care Complex Containing Pro-xylane in Menopausal Women: Results from a Multicentre, Evaluator-blinded, Randomized Study
Acta Dermato-Venereologica (2017); 97: 541–542
BOULOC A., ROO E., MOGA A., CHADOUTAUD B., ZOUBOULIS CC. (2017)
Vichy Laboratoires, 110 avenue Henri Barbusse, FR-92602 Asnières sur Seine, France.
Department of Dermatology Hospital Sur, Madrid, Spain.
Clinreal Online, Toulouse, France.
Departments of Dermatology, Venerology Allergology and Immunology, Dessau Medical Center, Dessau, Germany.
Synelvia, Labège, France.
In addition to the natural process of skin aging, the skin of women is significantly impacted during and after menopause. In post-menopausal women, the effect of oestrogen deprivation results in decreased collagen synthesis leading to skin atrophy, in reduced skin elasticity and in increased skin dryness. The aim of the present study was to assess the benefit of a fixed compensating skin care topical serum complex, containing the C-xylopyranoside derivative proxylane at 3%, hedione 1%, hydrovance and hepes 5% each (Laboratoires Vichy, Asnières sur Seine, France) and a moisturising cream (containing water, glycerin, cyclohexasiloxane, stearic acid, butylene glycol) versus the moisturizing cream alone during 60 days of daily application in post-menopausal women.
© 2017 Acta Dermato-Venereologica.